Carrasco-Diaz L, Gallardo A, Volta-Duran E, Virgili A, Paez D, Villaverde A
Int J Nanomedicine. 2025; 20:2445-2460.
PMID: 40034221
PMC: 11873025.
DOI: 10.2147/IJN.S499192.
Gollowitzer A, Pein H, Rao Z, Waltl L, Bereuter L, Loeser K
Nat Commun. 2025; 16(1):1774.
PMID: 40000627
PMC: 11861335.
DOI: 10.1038/s41467-025-56711-2.
He Y, Liu F, Li Q, Jiang Z
PLoS One. 2025; 20(1):e0307013.
PMID: 39883700
PMC: 11781745.
DOI: 10.1371/journal.pone.0307013.
Orehek S, Ramuta T, Lainscek D, Malensek S, Sala M, Bencina M
Nat Commun. 2024; 15(1):10801.
PMID: 39737979
PMC: 11686184.
DOI: 10.1038/s41467-024-55083-3.
Queen H, Cho C
Immunotherapy. 2024; 17(1):1-3.
PMID: 39690949
PMC: 11834414.
DOI: 10.1080/1750743X.2024.2442899.
PTPN23-dependent ESCRT machinery functions as a cell death checkpoint.
Song D, Cen Y, Qian Z, Wu X, Rivera K, Wee T
Nat Commun. 2024; 15(1):10364.
PMID: 39609437
PMC: 11604704.
DOI: 10.1038/s41467-024-54749-2.
5-Fluorouracil Effectively Depletes Tumor Induced Myeloid Derived Suppressor Cells in 4T1 Mammary Carcinoma Model.
Ramezani-Aliakbari K, Jalali S, Alinejad M, Jeddi-Tehrani M, Shabani M
Avicenna J Med Biotechnol. 2024; 16(4):244-250.
PMID: 39606677
PMC: 11589428.
DOI: 10.18502/ajmb.v16i4.16740.
Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance.
Mei T, Ye T, Huang D, Xie Y, Xue Y, Zhou D
Cell Oncol (Dordr). 2024; 47(6):2049-2071.
PMID: 39565509
DOI: 10.1007/s13402-024-01009-6.
Neutrophils under the microscope: neutrophil dynamics in infection, inflammation, and cancer revealed using intravital imaging.
Yam A, Jakovija A, Gatt C, Chtanova T
Front Immunol. 2024; 15:1458035.
PMID: 39439807
PMC: 11493610.
DOI: 10.3389/fimmu.2024.1458035.
C6 and KLRG2 are pyroptosis subtype-related prognostic biomarkers and correlated with tumor-infiltrating lymphocytes in lung adenocarcinoma.
Yuan S, Chen X, Qu Y, Zhang M
Sci Rep. 2024; 14(1):24861.
PMID: 39438534
PMC: 11496652.
DOI: 10.1038/s41598-024-75650-4.
Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward.
Antonelli A, Battaglia A, Sacco A, Petriaggi L, Giorgio E, Barone S
Front Oral Health. 2024; 5:1461022.
PMID: 39296524
PMC: 11408306.
DOI: 10.3389/froh.2024.1461022.
Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages.
You Y, Yan L, Ke H, Li Y, Shi Z, Zhou Z
Acta Pharmacol Sin. 2024; 46(2):430-447.
PMID: 39223367
PMC: 11747177.
DOI: 10.1038/s41401-024-01376-8.
The Hemagglutinin of Influenza A Virus Induces Ferroptosis to Facilitate Viral Replication.
Ouyang A, Chen T, Feng Y, Zou J, Tu S, Jiang M
Adv Sci (Weinh). 2024; 11(39):e2404365.
PMID: 39159143
PMC: 11497066.
DOI: 10.1002/advs.202404365.
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death.
Zhu X, Zhang W, Yu Z, Yang X, Li L, Chen C
Transl Cancer Res. 2024; 13(6):3031-3045.
PMID: 38988937
PMC: 11231791.
DOI: 10.21037/tcr-24-698.
Integrative machine learning and neural networks for identifying PANoptosis-related lncRNA molecular subtypes and constructing a predictive model for head and neck squamous cell carcinoma.
Wang Z, Cheng L, Huang J, Shen Y
Eur Arch Otorhinolaryngol. 2024; 281(10):5481-5495.
PMID: 38914821
DOI: 10.1007/s00405-024-08765-z.
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.
Mannion J, Gifford V, Bellenie B, Fernando W, Garcia L, Wilson R
Immunity. 2024; 57(7):1514-1532.e15.
PMID: 38788712
PMC: 11236506.
DOI: 10.1016/j.immuni.2024.04.025.
Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma.
Ward G, Zhang Z, Jueliger S, Potapov I, Davis M, Boxall A
Cancer Res Commun. 2024; 4(6):1441-1453.
PMID: 38727208
PMC: 11155518.
DOI: 10.1158/2767-9764.CRC-23-0415.
Potential Benefits of Green Tea in Prostate Cancer Prevention and Treatment: A Comprehensive Review.
Liu G, Yao Z, Chen G, Li Y, Liang B
Chin J Integr Med. 2024; 30(11):1045-1055.
PMID: 38561489
DOI: 10.1007/s11655-024-4100-2.
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.
Gulla A, Morelli E, Johnstone M, Turi M, Samur M, Botta C
Blood. 2024; 143(25):2612-2626.
PMID: 38551812
PMC: 11830986.
DOI: 10.1182/blood.2023022777.
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity.
Meier P, Legrand A, Adam D, Silke J
Nat Rev Cancer. 2024; 24(5):299-315.
PMID: 38454135
DOI: 10.1038/s41568-024-00674-x.